The impact of mergers on pharmaceutical R&D
- PMID: 21804580
- DOI: 10.1038/nrd3514
The impact of mergers on pharmaceutical R&D
Abstract
Mergers and acquisitions in the pharmaceutical industry have substantially reduced the number of major companies over the past 15 years. The short-term business rationale for this extensive consolidation might have been reasonable, but at what cost to research and development productivity?
References
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
